Table 1. Clinical Characteristics of FAP ATTR V30M and Control Patients.
| Patient | Sex | Age at FAP onset | Age at death | Time from FAP onset to death | Heart weight (g) at autopsy | Main disease |
|---|---|---|---|---|---|---|
| FAP 1 | M | 54 | 61 | 7 | 690 | FAP |
| FAP 2 | F | 28 | 38 | 10 | 240 | FAP |
| FAP 3 | M | 60 | 67 | 7 | 438 | FAP |
| FAP 4 | M | 29 | 38 | 9 | 420 | FAP |
| FAP 5 | M | 30 | 36 | 6 | 380 | FAP |
| FAP 6 | F | 55 | 63 | 7 | 460 | FAP |
| FAP 7 | M | 35 | 51 | 14 | 400 | FAP |
| FAP 8 | F | 63 | 69 | 5 | 240 | FAP |
| FAP 9 | F | 52 | 60 | 7 | 395 | FAP |
| FAP 10 | F | 34 | 47 | 13 | 450 | FAP |
| FAP 11 | M | 23 | 38 | 15 | 390 | FAP |
| FAP 12 | M | 31 | 42 | 11 | 340 | FAP |
| FAP 13 | M | 23 | 34 | 11 | 490 | FAP |
| FAP 14 | F | 28 | 42 | 14 | 320 | FAP |
| FAP 15 | M | 25 | 38 | 13 | 330 | FAP |
| FAP 16 | F | 37 | 47 | 10 | 300 | FAP |
| Control 1 | F | NA | 58 | NA | 430 | Gastric cancer |
| Control 2 | M | NA | 59 | NA | 320 | Colon cancer |
| Control 3 | M | NA | 54 | NA | 320 | Intrahepatic cholangiocarcinoma |
| Control 4 | M | NA | 43 | NA | 300 | Hepatocellular carcinoma |
| Control 5 | F | NA | 52 | NA | ND | Lung cancer |
| Control 6 | M | NA | 54 | NA | 500 | Lung cancer |
| Control 7 | F | NA | 46 | NA | 180 | Gastric cancer |
| Control 8 | M | NA | 56 | NA | 254 | Esophageal cancer |
| Control 9 | M | NA | 53 | NA | 294 | Multiple myeloma |
| Control 10 | M | NA | 57 | NA | 230 | Malignant lymphoma |
| Control 11 | M | NA | 59 | NA | 190 | Lung cancer |
M, male; F, female; NA, not applicable; ND, no data.